Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner

Neuro-Oncology

Volumn 13, Issue 1, 2011, Pages 28-41

  Byer, Stephanie J ^a   Eckert, Jenell M ^a   Brossier, Nicole M ^a,b   Clodfelder Miller, Buffie J ^a   Turk, Amy N ^a   Carroll, Andrew J ^c   Kappes, John C ^d   Zinn, Kurt R ^e   Prasain, Jeevan K ^f,h   Carroll, Steven L ^a,b,g  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e University of Alabama at Birmingham   (United States)

^f University of Alabama at Birmingham   (United States)

^g University of Alabama at Birmingham   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Calcium signaling; Neurofibromatosis; Schwann cell; Steroid receptors; Xenograft model

Indexed keywords

AFIMOXIFENE; CALMODULIN; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; FULVESTRANT; G PROTEIN COUPLED RECEPTOR 30; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; TAMOXIFEN; TRIFLUOPERAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MITOGENESIS; MOUSE; NERVE SHEATH TUMOR; NEUROFIBROMA; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; MICE; NERVE SHEATH NEOPLASMS; NEUROFIBROMA, PLEXIFORM; NEUROFIBROMATOSIS 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TAMOXIFEN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79951596956     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq146     Document Type: Article

References (40)

1. Gutmann DH. The neurofibromatoses: when less is more. Hum Mol Genet. 2001;10:747-755. (Pubitemid 32331584)
2. Carroll SL, Stonecypher MS. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations. J Neuropath Exp Neurol. 2004;63:1115-1123. (Pubitemid 39492017)
3. Carroll SL, Stonecypher MS. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. II. The role of dysregulated growth factor signaling. J Neuropath Exp Neurol. 2005;64:1-9. (Pubitemid 40189473)
4. Evans D G R, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. J Med Genet. 2002;39:311-314. (Pubitemid 34526349)
5. st ed. Lyon: IARC Press; 2000:172-174.
6. Lewis JJ, Brennan MF. Soft tissue sarcomas. Curr Probl Surg. 1996;33:817-872.
7. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986;57:2006-2021. (Pubitemid 16113778)
8. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumours in neurofibromatosis 1. Cancer Res. 2002;62:1573-1577. (Pubitemid 34407825)
9. Ferner RE, O'Doherty MJ. Neurofibroma and schwannoma. Curr Opin Neurol. 2002;15:679-684. (Pubitemid 35471675)
10. Stonecypher MS, Byer SJ, Carroll SL. Activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors. Oncogene. 2005;24:5589-5605. (Pubitemid 43119353)
11. Frohnert PW, Stonecypher MS, Carroll SL. Lysophosphatidic acid promotes the proliferation of adult Schwann cells isolated from axotomized sciatic nerve. J Neuropath Exp Neurol. 2003;62:520-529. (Pubitemid 36560193)
12. Stonecypher MS, Chaudhury AR, Byer SJ, Carroll SL. Neuregulin growth factors and their erbB receptors form a potential signaling network for schwannoma tumorigenesis. J Neuropath Exp Neurol. 2006;65:162-175.
13. Carroll SL, Miller ML, Frohnert PW, Kim SS, Corbett JA. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci. 1997;17:1642-1659. (Pubitemid 27089810)
14. Nelson RE, Grebe SK, Okane DJ, Singh RJ. Liquid chromatographytandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem. 2004;50:373-384. (Pubitemid 38156379)
15. Perry RR, Kang Y, Greaves B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and-independent human breast cancer cells. Ann Surg Oncol. 1995;2:238-245.
16. Mandlekar S, Kong A N T. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001;6:469-477. (Pubitemid 33078758)
17. Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem Biophys Res Comm. 2005;336:1221-1226. (Pubitemid 41383452)
18. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307:1625-1630. (Pubitemid 40354745)
19. Jung-Testas I, Baulieu EE. Steroid hormone receptors and steroid action in rat glial cells of the central and peripheral nervous system. J Steroid Biochem Mol Biol. 1998;65:243-251. (Pubitemid 28335612)
20. Walter G, Liebl R, von Angerer E. 2-Phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2004;88:409-420. (Pubitemid 38625606)
21. Kitawaki J, Fukuoka M, Yamamoto T, Honjo H, Okada H. Contribution of aromatase to the deoxyribonucleic acid synthesis of MCF-7 human breast cancer cells and its suppression by aromatase inhibitors. J Steroid Biochem Mol Biol. 1992;43:267-277.
22. Xia YQ, Chang SW, Patel S, Bakhtiar R, Karanam B, Evans DC. Trace level quantification of deuterated 17beta-estradiol and estrone in ovariectomized mouse plasma and brain using liquid chroatography/tandem mass spectrometry following dansylation reaction. Rapid Commun Mass Spectrom. 2004;18:1621-1628. (Pubitemid 38937375)
23. Jung-Testas I, Schumacher M, Bugnard H, Baulieu EE. Stimulation of rat Schwann cell proliferation by estradiol: synergism between the estrogen and cAMP. Brain Res Dev Brain Res. 1993;72:282-290. (Pubitemid 23116176)
24. Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182, 780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer. 2000;89:817-825.
25. Clarke R, Leonessa F, Welch JN, Skaar TC. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev. 2001;53:25-71. (Pubitemid 32173107)
26. O'Brian CA, Ioannides CG, Ward NE, Liskamp RE. Inhibition of protein kinase C and calmodulin by the geometric isomers cis-and transtamoxifen. Biopolymers. 1990;29:97-104. (Pubitemid 20055805)
27. Gulino A, Barrera G, Vacca A, et al. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. Cancer Res. 1986;46:6274-6278. (Pubitemid 17221770)
28. O'Brian CA, Housey GM, Weinstein IB. Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue. Cancer Res. 1988;48:3626-3629.
29. Cheng AL, Chuang SE, Fine RL, et al. Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen. Biochem Pharmacol. 1998;55:523-531. (Pubitemid 28070158)
30. Lien EA, Solheim E, Ueland PM. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Res. 1991;51:4837-4844.
31. Lim CK, Yuan ZK, Lamb JH, White IN, De Matteis F, Smith LL. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. Carcinogenesis. 1994;15:589-593. (Pubitemid 24124398)
32. MacCallum J, Cummings J, Dixon JM, Miller WR. Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours. Br J Cancer. 2000;82:1629-1635. (Pubitemid 30229571)
33. Zhou W, Koldzic-Zivanovic N, Clarke CH, et al. Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology. 2002;75:24-33. (Pubitemid 34124214)
34. Kimelberg HK, Jin Y, Charniga C, Feustel PJ. Neuroprotective activity of tamoxifen in permanent focal ischemia. J Neurosurg. 2003;99:138-142. (Pubitemid 36753888)
35. Bigler LR, Tate Thigpen J, Blessing JA, Fiorica J, Monk BJ, Gynecologic Oncology Group. Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Int J Gynecol Cancer. 2004;14:871-287.
36. The Arimidex, Tamoxifen, Alone or in Combination Trialists' Group, Buzdar AU, et al. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol. 2007;7:633-643.
37. Fishbein L, Zhang X, Fisher LB, et al. In vitro studies of steroid hormones in neurofibromatosis 1 tumors an Schwann cells. Mol Carcinog. 2007;46:512-523. (Pubitemid 47068070)
38. Jung-Testas I, Do Thi A, Koenig H, et al. Progesterone as a neurosteroid: synthesis and actions in rat glial cells. J Steroid Biochem Mol Biol. 1999;69:97-107. (Pubitemid 29305527)
39. Perrin GQ, Li H, Fishbein L, et al. An orthotopic xenograft model of intraneural NF1 MPNST suggests a potential associaation between steroid hormones and tumor cell proliferation. Lab Invest. 2007;87:1092-1102. (Pubitemid 47609027)
40. Dang I, De Vries GH. Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor BB. J Neurosci Res. 2005;79:318-328. (Pubitemid 40278346)